Helsinki University Hospital
Helsinki, Finland
25 recruiting
Showing 1–20 of 65 trials
Recruiting
Phase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
ObesityOverweightAtherosclerotic Cardiovascular Disease
Amgen12,800 enrolled774 locationsNCT07037433
Recruiting
Not Applicable
Execise Intervention in Adult Severe Asthma
AsthmaSevere Asthma
Helsinki University Central Hospital60 enrolled1 locationNCT07655037
Recruiting
Phase 3
PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia
Preeclampsia
Lina Bergman294 enrolled17 locationsNCT06033131
Recruiting
Phase 3
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
Bronchiectasis
Boehringer Ingelheim1,755 enrolled494 locationsNCT06872892
Recruiting
Not Applicable
Protective Ileostomy Versus Protective Colostomy in Anterior Rectal Resection
Stoma - IleostomyStoma Colostomy
Helsinki University Central Hospital350 enrolled3 locationsNCT06650085
Recruiting
Phase 2
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small Cell Lung
Janssen Research & Development, LLC480 enrolled201 locationsNCT06667076
Recruiting
Phase 3
A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
Lupus Erythematosus, Systemic
Janssen Research & Development, LLC600 enrolled169 locationsNCT07438496
Recruiting
Not Applicable
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
Deep Venous ThrombosisVenous ThromboembolismPost Thrombotic Syndrome
Inari Medical300 enrolled64 locationsNCT05701917
Recruiting
Phase 3
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
ObesityHeart Failure With Preserved Ejection FractionHeart Failure With Mildly Reduced Ejection Fraction
Amgen5,056 enrolled605 locationsNCT07037459
Recruiting
Not Applicable
Study of the Kono-S Anastomosis Versus the Side-to-side Functional End Anastomosis
Crohn's Disease
Weill Medical College of Cornell University600 enrolled15 locationsNCT03256240
Recruiting
Not Applicable
The T-REX Trial: Tailored Regional External Beam Radiotherapy in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macrometastases.
Breast Cancer
Region Skane1,350 enrolled30 locationsNCT05634889
Recruiting
Phase 4
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Severe Hemophilia A
Octapharma28 enrolled18 locationsNCT05935358
Recruiting
Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
Newly Diagnosed Philadelphia (Ph)-Negative B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
Amgen304 enrolled192 locationsNCT04994717
Recruiting
Not Applicable
The Finnish Uterine Prolapse Surgery Trial (The Fin-UP Trial)
Pelvic organ prolapse (POP)Uterine ProlapsePelvic Organ Prolapse Vaginal Surgery
Tampere University Hospital426 enrolled6 locationsNCT07566949
Recruiting
Phase 2Phase 3
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Advanced Melanoma
Eikon Therapeutics740 enrolled107 locationsNCT06697301
Recruiting
Phase 3
FMT Capsules for rCDI
FMTClostridioides Difficile Infection Recurrence
Helsinki University Central Hospital76 enrolled1 locationNCT07458984
Recruiting
Phase 2Phase 3
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
Focal Epilepsy
Biohaven Therapeutics Ltd.390 enrolled174 locationsNCT06309966
Recruiting
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants
Retinitis PigmentosaInherited Retinal Degeneration
Jaeb Center for Health Research1,500 enrolled36 locationsNCT05589714
Recruiting
Phase 3
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
Ischemic Stroke; Ischemic Attack, Transient
Janssen Research & Development, LLC15,000 enrolled880 locationsNCT05702034
Recruiting
Phase 2
Safety of Antithrombotic Heparin Proteoglycan Mimetic APAC in Peripheral Arterial Occlusive Disease and Chronic Limb-threatening Ischemia
Peripheral arterial occlusive diseaseChronic Limb Threatening Ischemia
Aplagon Oy42 enrolled3 locationsNCT07352800